EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

USP13 stabilizes EPHA2 to promote M2 macrophage polarization and cervical cancer progression

Tingting Qi, Fanye Zeng, Tingchuan Xiong, Liting Sun

Letters in Drug Design & Discovery · 2026-03 · 23 (3) · 100423

DOI: 10.1016/j.lddd.2026.100423 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Letters in Drug Design & Discovery, 2026-03. Verfasst von Tingting Qi und 3 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

• EPHA2 drives cervical cancer progression by inducing M2 macrophage polarization. • USP13 stabilizes EPHA2 protein by mediating the deubiquitination. • USP13 targets EPHA2 to affect M2 macrophage polarization and cervical cancer cell progression. • USP13/EPHA2 promotes tumor growth and M2 macrophage polarization in vivo .

Zitieren

APA

Qi, T., Zeng, F., Xiong, T., & Sun, L. (2026). USP13 stabilizes EPHA2 to promote M2 macrophage polarization and cervical cancer progression. Letters in Drug Design & Discovery, 23(3), 100423. https://doi.org/10.1016/j.lddd.2026.100423

Vancouver

Qi T, Zeng F, Xiong T, Sun L. USP13 stabilizes EPHA2 to promote M2 macrophage polarization and cervical cancer progression. Letters in Drug Design & Discovery. 2026;23(3):100423. doi:10.1016/j.lddd.2026.100423

BibTeX
@article{Qi2026,
  author = {Qi, Tingting and Zeng, Fanye and Xiong, Tingchuan and Sun, Liting},
  title = {USP13 stabilizes EPHA2 to promote M2 macrophage polarization and cervical cancer progression},
  journal = {Letters in Drug Design & Discovery},
  year = {2026},
  volume = {23},
  number = {3},
  pages = {100423},
  doi = {10.1016/j.lddd.2026.100423}
}
Kostenlos starten →